CELH
Celsius Holdings, Inc.
CELH has the edge over LOPE overall, supported by stronger fundamentals.
LOPE
Grand Canyon Education, Inc.
LOPE has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
LOPE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Unavailable |
LOPE's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
LOPE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $118 | — |
| Current | 13x | $118 | — |
| Cheap | 15x | $144 | +22% |
| Fair | 19x | $174 | +47% |
| Expensive | 22x | $202 | +71% |
Historical ranges are pointers, not guarantees.
LOPE has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
LOPE Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for LOPE, with profitability improving.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
LOPE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.64 | +14% |
| Q3 2026 | $9.35 | +26% |
| Q2 2026 | $8.26 | +0.1% |
| Q1 2026 | $7.99 | +0.4% |
| Q4 2025 | $7.71 | -0.3% |
| Q3 2025 | $7.41 | -2.6% |
| Q2 2025 | $8.25 | +12% |
| Q1 2025 | $7.96 | +11% |
| Q4 2024 | $7.73 | +14% |
LOPE has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over LOPE on profitability, with a higher operating margin.
LOPE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.3M | +2.4% |
| Q2 2026 | $264M | +6.7% |
| Q1 2026 | $308.8M | +6.7% |
| Q4 2025 | $308.1M | +5.3% |
| Q3 2025 | $261.1M | +9.6% |
| Q2 2025 | $247.5M | +8.8% |
| Q1 2025 | $289.3M | +5.3% |
| Q4 2024 | $292.6M | +5.1% |
LOPE's revenue has grown year over year for 17 quarters in a row: $267M last quarter, up 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | +12 points |
| Q2 2026 | 22% | +1.1 points |
| Q1 2026 | 31% | +0.5 points |
| Q4 2025 | 35% | +0.9 points |
| Q3 2025 | 6.9% | -13 points |
| Q2 2025 | 21% | +2.1 points |
| Q1 2025 | 30% | -0.3 points |
| Q4 2024 | 34% | -1 points |
LOPE's operating margin was 19% last quarter, up 12 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
LOPE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$36M | +$22.3M |
| Q2 2026 | $97.9M | -15% |
| Q1 2026 | $80.1M | +36% |
| Q4 2025 | $122.9M | -2.5% |
| Q3 2025 | -$58.3M | -$19.3M |
| Q2 2025 | $115.4M | +29% |
| Q1 2025 | $58.7M | -23% |
| Q4 2024 | $126.1M | +19% |
LOPE usually generates cash, though not every quarter: the latest was −$36M, but it generated $265M over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
LOPE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -450K shares |
| 1 year | -7.6% | -2.1M shares |
| 3 years | -14% | -4.1M shares |
| 5 years | -42% | -18.5M shares |
| Available history | -46% | -22.3M shares |
LOPE has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $75.1M |
| Q2 2026 | $75.3M |
| Q1 2026 | $127.9M |
| Q4 2025 | $100M |
| Q3 2025 | $39.5M |
| Q2 2025 | $47.4M |
| Q1 2025 | $77.9M |
| Q4 2024 | $64.8M |
LOPE spent $378M buying back its own shares over the past year, up 65% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
LOPE Net Leverage
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
LOPE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.3 | Neutral |
| Stochastic | 14.7 | Oversold |
LOPE's weekly RSI is 30 (neutral) and its Stochastic is 15 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
LOPE PE vs Consumer Defensive Sector
| Metric | LOPE | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 19x | 35% below |
| PE % | 1 | 18 | 17 pts below |
LOPE has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over LOPE on trend strength, trading above more of its moving averages.
LOPE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $146.3 | 20% below |
| 20 week MA | $147.5 | 20% below |
| 50 week MA | $156.6 | 25% below |
| 100 week MA | $170.3 | 31% below |
| 200 week MA | $149.5 | 21% below |
LOPE is in a downtrend: it's below all five of its weekly moving averages, and 21% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
LOPE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $97.0 | $94.9 | -2.1% |
| 2021 | $94.9 | $85.3 | -10% |
| 2022 | $85.3 | $106.1 | +24% |
| 2023 | $106.1 | $132.0 | +24% |
| 2024 | $132.0 | $163.8 | +24% |
| 2025 | $163.8 | $168.3 | +2.8% |
| 2026 YTD | $168.3 | $117.8 | -30% |
LOPE has the edge over CELH on returns for 2026, with the stronger performance.